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Objectives: Decellularization of aortic valve allografts in advance of transplantation
is a promising approach to overcome immune-induced early graft failure. In this
study the effects of in vitro cell extraction on extracellular matrix molecules and in
vivo remodeling of decellularized aortic valves were investigated in a heterotopic
aortic valve rat implantation model.
Methods: Rat aortic valve conduits were decellularized by a 2-step detergent–
enzymatic extraction method involving sodium dodecyl sulfate in combination with
RNase and DNase. Cellular and acellular allogeneic (2, n  4) and syngeneic
valve grafts (2, n  3) were grafted infrarenally into the descending aorta for 21
days. Immunohistochemical techniques were used to study extracellular matrix
constitution (elastin, collagen, fibronectin, and chondroitin sulfate) and cellular
infiltration.
Results: The decellularization procedure resulted in a complete loss of all cellular
structures from the entire valve conduit with minimal damage to the extracellular
matrix. All transplanted cellular allografts became deformed, swollen, and acellular
with major changes in extracellular matrix structure. The transplanted decellularized
allografts, however, retained normal preserved valve leaflets comparable to trans-
planted cellular and acellular syngeneic grafts. With the exception of cellular
syngeneic grafts, all other grafts showed retrovalvular thrombi.
Conclusions: Damage to the valves caused by decellularization technique is much
less than the damage caused by the recipient’s immune response. In vitro removal
of viable cells in (cryopreserved) homografts may decrease graft failure. Seeding
with autologous or major histocompatibility complex–matched donor endothelial
cells will be necessary to diminish damage induced by an absent blood-tissue
barrier.
Aortic valve allografts (AVA) ultimately fail in the long term, withan effective lifetime around 15 years1 in adults and much less inchildren.2 There is evidence that early AVA failure is caused bya donor-specific immune response.3,4 Aortic valve transplantationin the rat has shown that AVA are capable of eliciting an immuneresponse that is associated with early graft destruction.5-7
The concept of engineering the valve graft before transplantation could be a
solution in overcoming valve failure. A promising approach is the use of decellu-
larized AVA. The remaining extracellular matrix (ECM) can then be seeded with
autologous cells of the recipient before transplantation in vitro or can be repopulated
by recipient’s cells in vivo after implantation.
Several methods have been developed to produce completely acellular heart
valve tissue matrices using multistep detergent–enzymatic extraction,8 Triton de-
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tergent,9 or trypsin/ethylenediaminetetraacetic acid.10 A
more recent protocol using sodium dodecyl sulfate (SDS) in
the presence of protease inhibitors was successful for aortic
valve conduit decellularization, and histological analysis
showed that the major structural components seemed to be
maintained.11 Additional efforts should be given to study
the effect of cell removal on different types of ECM mol-
ecules and the remodeling of the ECM in the transplanted
aortic valve.
Heterotopic aortic valve implantation models in geneti-
cally identical rat inbred strains are well described.5-7 Such
models are essential in studying the effect of cell removal
on the in vivo behavior of transplanted aortic valves. In this
report we demonstrate that complete rat aortic valve con-
duits treated with SDS, RNase, and DNase result in a
completely acellular graft with minimal remodeling to the
ECM.
Materials and Methods
Experimental Design
This study included 4 different groups of animals, which consisted
of cellular allogeneic (n 4), acellular allogeneic (n 4), cellular
syngeneic (n  3), and acellular syngeneic (n  3) heterotopic
aortic valve transplantations. Female inbred WAG-Ry (RT-1u/
RyHSD) and Brown Norway (RT-1n/RyHSD) rats 9 to 12 weeks
old (Harlan CPB, Horst, The Netherlands) were used as syngeneic
and allogeneic donors, respectively. Male inbred WAG-Ry (RT-
1u/RyHSD) 9 to 12 weeks old were used as recipients. All animals
were killed 21 days after the valve transplantation. Four nonim-
planted cellular valve conduits were used to study normal valve
histology, and an additional set of animals was used to optimize
the decellularization method.
All experiments were approved by the committee on animal
welfare of the Leiden University Medical Centre (LUMC), The
Netherlands. Rats were housed under standard conditions in con-
ventional cages, were given standard diet and water ad libitum, and
have received humane care in compliance with the Guide for the
Care and Use of Laboratory Animals.
Aortic Valve Implantation
Donor operation. Animals were killed by cervical transloca-
tion, after which a median sternotomy was performed followed by
en bloc removal of the lungs. The innominate artery, left common
carotid artery, and left subclavian artery were dissected and ligated
with 8-0 nylon sutures (Ethicon, Johnson & Johnson Intl, Brussels,
Belgium), as well as both coronary arteries, while intermittently
moistening the tissue with Hanks balanced salt solution (HBSS)
under sterile conditions. The aortic valve conduit consists of the
aortic root, ascending aorta, aortic arch, and descending aorta. A
small rim of left ventricular outflow tract myocardium was dis-
sected free. The major part of the tunica adventitia was removed.
The conduits were then stored in heparinized buffered saline (12.5
U/mL) on ice or decellularized as described below.
Decellularization of aortic valve conduits. Various decellular-
ization protocols were tested for cell extraction capacity of rat
aortic valves (Table 1). First a Triton X-100 decellularization
method12 was used with varying detergent concentrations (1%-
5%). A second enzymatic extraction method using 0.05% trypsin
was used mainly as previously described10 but with extended
washing steps (0.5-1.5 hours). Thirdly, a combination of these 2
protocols consisting of a 0.05% trypsin treatment followed by a
24-hour Triton X-100 treatment was tested. The fourth method was
based on a 0.1% SDS cell extraction method,13 to which a DNase
and RNase step was added. After the valves were treated for 24
hours at 4°C with 0.1% SDS in distilled water, they were placed in
a solution containing RNase A (20 g/mL) and DNase (0.2 mg/
mL) for 1 hour in HBSS at room temperature, followed by washing
with HBSS at 4°C for 48 hours to remove residual substances. All
steps were conducted under continuous shaking (600 rpm). Pend-
ing the transplantation the grafts were placed in a sterile heparin-
ized saline solution for maximally 5 hours at 4°C.
Recipient procedure. The heterotopic aortic valve transplanta-
tion described by Oei and colleagues7 was slightly modified. In
short the recipient rats were anaesthetized with halothane admin-
istered by a vaporizer with a waste gas scavenging system in
combination with NO2/O2 in a 50:50 or 60:40 ratio. A vapor
concentration of 3% to 4% was used for induction, and anesthesia
was maintained with a 0.75% to 1.5% halothane concentration. A
midline laparotomy was performed, the intestines were mobilized
to the right, and the aorta was dissected away from the vena cava
from the level of the renal arteries to the aortic bifurcation and
crossclamped with a Lee clamp. Within this segment 2 incisions
were made to create the distal and proximal openings for the
anastomoses. The anastomoses were made, within 50 minutes after
clamping, with a continuous 10-0 suture (Ethicon), flushing inter-
mittently with heparinized buffered saline solution (12.5 U/mL).
After 21 days the explanted U-shaped aortic valve conduit was cut
a few millimeters above the annulus and the remaining piece was
split longitudinally into 3 valve cusp–containing symmetric rect-
angular pieces.
Histology
All the valve tissues were fixed overnight in 2% acetic acid in
100% ethanol or in 4% paraformaldehyde, dehydrated in graded
ethanol and xylene, and subsequently embedded in paraffin. Serial
sagittal sections of 5 m were cut and mounted onto egg white/
glycerine-coated glass slides for histological and immunohisto-
chemical analysis. Parallel sections were routinely stained with
hematoxylin-eosin. Resorcin-fuchsin staining was used to visual-
ize elastic laminae. Sirius red was used to detect collagen and
Alcian blue to detect glycosaminoglycans (GAG).
TABLE 1. Decellularization methods
Treatment Concentration Duration (h)
Triton X-100 1%–5% 24
Trypsin 0.5% 0.5–1.5
Trypsin/Triton X-100 0.5%/1%–5% 0.5–1.5/24
SDS 0.1%–1% 24
SDS, Sodium dodecyl sulfate.
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Immunohistochemistry
Smooth muscle cells were visualized with the 1A4 mouse anti-
human antibody recognizing -smooth muscle actin (A2547,
Sigma, St Louis, Mo). Extracellular matrix proteins were detected
using a mouse anti-chicken chondroitin sulfate (6505, Bio-Yeda,
Israel) monoclonal and a rabbit anti-human fibronectin (A245,
Dako, Denmark) polyclonal antibody.
Sections were deparaffinated and dehydrated in xylene and
graded ethanol and treated with 0.3% H2O2 in phosphate-buffered
saline solution (PBS; 10 minutes) to quench endogenous peroxi-
dase activity. Thereafter the sections were washed twice in PBS
and once in PBS containing 0.05% Tween-20. Routine immuno-
staining was performed by overnight incubation with the primary
antibodies 1A4 (1:2000), anti-chondroitin sulfate (1:200), and anti-
fibronectin (1:400), diluted in PBS containing 0.05% Tween and
1% bovine serum albumin (BSA, Sigma). Control sections were
incubated with PBS. After overnight incubation, sections were
again washed twice in PBS and once in PBS with 0.05% Tween-
20. To detect bound antibodies the sections were incubated with
horseradish peroxidase-conjugated swine anti-rabbit (1:250, Dako-
patts, Glostrup, Denmark) or rabbit anti-mouse antibody (1:250,
Dako) diluted in PBS, containing 1% BSA and 0.05% Tween, for
3 hours at room temperature. Sections were washed again and
bound immunocomplexes were visualized by treatment with
0.04% diaminobenzidine tetrahydrochloride and 0.06% H2O2 in
0.05 mol/L Tris-maleate buffer (pH 7.6) for 8 minutes at room
temperature. Sections were counterstained with hematoxylin for 10
seconds, dehydrated in graded ethanol, and mounted in Entellan
(Merck, Darmstadt, Germany).
Results
Histology of Normal and Decellularized Valves
Normal valve. Rat aortic valve leaflets consist of 5 to 6
cell layers and do not display a typical 3-layered structure
(Figure 1, a) as is seen in human and porcine aortic valves.
The mesenchymal cells in the leaflets do not express
-smooth muscle cell (SMC)–specific actin. A small
amount of elastin is found in the valve leaflet. At the basis
of the valve 4 to 5 lamellae are observed (Figure 1, b), and
at the ventricular side of the leaflet only 1 very thin and
mostly incomplete lamella of elastin is present. One of the
major components of the ECM of the rat aortic valve leaflet
is collagen, comprising approximately three quarters of the
leaflet (Figure 1, c) predominantly at the arterial side.
GAGs, chondroitin sulfate (CS), and fibronectin (FN) are
found at the basis of the valve and at the ventricular and
arterial side of the leaflet (Figure 1, d, e, f).
Decellularized valve. Treatment of the valves with a 1%
Triton X-100 solution for a period of 24 hours showed no
change in cellularity compared with a normal rat aortic
valve (Figure 2, a). Increasing the concentration to 5%
resulted into only a slight decrease in valve cells (Figure 2,
b), with the SMCs not being removed from the aortic wall.
The 0.05% trypsin treatment resulted in a complete loss of
valve cells (Figure 2, c), but cells in the media of the aortic
wall could not be removed. Combination of the Triton
X-100 and trypsin protocols resulted in complete decellu-
larization of the entire conduit. However, analysis of the
decellularization-induced ECM damage (Figure 2, d)
Figure 1. a to l, Histology of a normal adult rat aortic valve (left
panel). The valve leaflets consist of 5 to 6 cell layers (a) contain-
ing only a small amount of elastin (Elas; b). The ECM is mainly
composed of thick layers of collagen (Col; c), while glycosami-
noglycans (GaG; d) as chondroitin sulfate (CS; e) and fibronectin
(FN; f) are abundantly expressed. The aortic valve after decellu-
larization using 0.1% SDS with DNase and RNase (right panel)
shows removal of all cellular components (g) while the elastin
and collagen fiber distribution were not affected (h, i). The single
elastic lamella in the leaflet is indicated by an arrow. Only a
considerable washout of CS was seen for the GAG (j, k, l). Arterial
(A) and ventricular (V) side of the valve; valve basis (B); valve
leaflet (L); hematoxylin-eosin (HE).
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showed an almost complete loss of elastin, GAGs including
CS, a disruption of the collagen fibers, and a decrease in FN.
Furthermore, all protocols comprising trypsin resulted in a
severely damaged myocardial rim and aortic wall, making it
impossible to create stable suture lines for the anastomosis.
For this reason, we introduced a fourth decellularization
method based on SDS. SDS removes all the cells from the
myocardial rim, aortic valve, and aorta. However, many
acellular basophilic nuclear residues were not washed out
from the tissue. To remove these remnants we added DNase
and RNase. Histological analysis of valves revealed that this
procedure resulted into a complete loss of cellular structures
across the complete thickness of the valve leaflet (Figure 1,
g). There was no loss or disruption of the elastic lamellae
(Figure 1, h), and also the collagen distribution appeared to
have been preserved (Figure 1, i). Alcian blue staining
showed no major changes in GAG distribution after decel-
lularization treatment (Figure 1, j). Immunohistochemical
staining, however, showed that the decellularization treat-
ment had resulted in a considerable washout of CS and FN
throughout the complete leaflet but was still abundantly
present in the basis of the valve (Figure 1, k, l).
Aortic Valve Transplantations
Cellular allogeneic grafts. In all grafts retrovalvular
thrombi were seen in the aortic sinuses (Table 2). Like the
syngeneic control transplantations (see below) all grafts
showed little to moderate intimal proliferation (Figure 3, a,
b). These intimal proliferations were positive for SMC-actin
(not shown), collagen, GAG, CS, and FN (Figure 3, c, d, e).
Figure 2. a to d, Various described methods tested to decellularize aortic valves did not remove the cells at all from
the valve in the rat (a) or remnants of cells were found at the basis of the leaflet (b) or in the aortic wall (inset
in c). Severe damage in leaflets was seen in protocols comprising trypsin (c, d). Arterial (A) and ventricular (V) side
of the valve; hematoxylin-eosin staining (HE); Trypsin (Tryp).
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The allogeneic valve leaflets were deformed and swollen
while the cells had disappeared (Figure 3, a, b). Major
changes in ECM structure, as indicated by a disruption and
fragmentation of the elastic lamina at the ventricular side,
was seen in all these allografts. The collagen fibers were less
compact (Figure 3, c) and there was a decrease of CS
(Figure 3, d). No loss of GAG was observed in the valve
leaflets. Furthermore, a slight decrease of FN was found in
3 grafts (Figure 3, e) and all grafts were covered with a thin
layer of fibronectin.
Acellular allogeneic grafts. All allogeneic acellular
grafts contained retrovalvular thrombi. The valve leaflets
showed normal morphology (Figure 3, f, g) with an intact
elastic lamina on the ventricular side and regular collagen
(Figure 3, h) and GAG distributions. In 2 of 4 grafts intimal
proliferation at the ventricular side was observed. A similar
decrease in CS expression was found as compared with a
nontransplanted, treated valve (compare Figure 3, i, and
Figure 1, k). There was also a slight decrease of FN expres-
sion in 3 of 4 grafts (compare Figure 3, j, and Figure 1, l).
Most valves were covered by a thin layer of FN. Ingrowth
of -smooth muscle actin–positive cells at the base of the
leaflet was observed (Figure 4, a).
Acellular syngeneic grafts. All acellular syngeneic
grafts contained retrovalvular thrombi and showed moder-
ate to severe intimal proliferations extending from the prox-
imal anastomoses to the ventricular side of the valve. The
intimal proliferations were positive for SMC-actin (Figure
4, a), collagen, GAG, CS (Figure 4, b), and FN (Figure 4, c).
In all 3 grafts proliferating intimal cells had migrated into
the valve leaflet. In most leaflets only the basis of the valve
was populated by recipients’ cells, but in 1 valve leaflet
almost three quarters of the leaflet was repopulated (Figure
4, a). All valve leaflets showed normal morphology with
intact elastic lamellae on the ventricular side and regular
collagen and GAG distributions. Both the CS and FN con-
tent was similar as in the acellular allogeneic group, but in
the leaflet that was infiltrated by proliferating intimal cells
expression was similar to a fresh leaflet (Figure 4, b, c).
Cellular syngeneic grafts. None of these control grafts
were affected by thrombosis in the valve sinuses. All grafts
showed moderate to severe intimal proliferation extending
from the proximal anastomoses to the ventricular side of the
valve and sometimes even extending over the entire valve
leaflet. The intimal proliferations stained positive for anti-
SMC actin, collagen, GAGs, CS, and fibronectin. Except for
these surgically induced intimal proliferations the valves did
not show any difference in morphology and matrix consti-
tution as compared with a nontransplanted aortic valve.
Aortic Wall
Decellularization of the aorta using SDS in combination
with DNase/RNase resulted in a complete loss of cellular
structures from both the media and adventitia. The tunica
media became more compact with smaller interlamellar
spaces after decellularization (Figure 4, d, e). The collagen
distribution in the adventitia was not changed after treat-
ment. GAG distribution showed a more compact appear-
ance similar to that of the elastic lamellae. There was almost
no decrease in CS and FN expression.
TABLE 2. Histological and morphological evaluation of transplanted valves
Retro valvular thrombus Preserved leaflets
Matrix
Elastin Collagen GAG FN CS
Cellular syngeneic
1 No Yes     
2 No Yes     
3 No Yes     
Acellular syngeneic
1 Yes Yes     
2 Yes Yes    2 +
3 Yes Yes    2 +
Cellular allogeneic
1 Yes Deformed  +  2 2
2 Yes Deformed 2 +   2
3 Yes Deformed 2 +  2 +
4 Yes Deformed 2 2  2 2
Acellular allogeneic
1 Yes Yes    2 +
2 Yes Yes     +
3 Yes Yes    2 +
4 Yes Yes    2 +
Extracellular matrix constitution (glycosaminoglycans, GAG; fibronectin, FN; and chondroitin sulfate, CS) was compared to fresh untransplanted valve
leaflets as similar (), slight decrease (2), or considerable decrease (+).
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A complete loss of medial SMCs in the aortic root was
found in transplanted cellular allogeneic conduits. The loss
of SMC was accompanied by a decrease in GAG and CS,
and a multifocal disruption of the elastin fibers (Figure 4, f).
In transplanted acellular allogeneic conduits, however, the
medial elastic fibers were normally arranged (Figure 4, g)
and also the amount of collagen, GAG, and FN in the media
did not differ from a nontransplanted acellular aortic con-
duit. Only a decrease in medial CS expression as compared
with a nontransplanted, treated valve conduit was found.
The media was still acellular and negative for anti-SMC
actin.
The matrix constitution in the controls (acellular synge-
neic) did not differ from the acellular allogeneic group. The
media was also still acellular and negative for anti-SMC
actin. There was no loss or disruption of elastic fibers and
also the amount of collagen, GAG, and FN was unchanged.
Discussion
Extraction of cellular components from heart valve allo-
grafts is believed to minimize the immunologically induced
structural changes leading to graft failure. Several authors
have developed decellularization techniques followed by in
vitro reseeding with autologous cells10,14 or allowing in-
growth of host cells into the graft after transplanta-
tion.8,10,15,16 The effect of cell extraction on different types
of ECM proteins, however, and the reconstitution of ECM
and valve cells after in vivo implantation have not been
studied in detail yet. To answer these questions we have
chosen to analyze the effect of decellularization on heart
valve conduits in rat inbred strains, which are genetically
well described and have provided important insights into the
role of the immune response in allograft heart valve fail-
ure.5,6,17
In the present study we developed a 2-step detergent–
enzymatic extraction method involving SDS in combination
with RNase and DNase to produce completely acellular rat
aortic heart valve conduits suitable for implantation.
Against our expectations previously described methods to
decellularize larger canine,8 porcine,9 and human10,14 aortic
valves failed in removing cells from the small and compact
rat aortic valves. Procedures to detach cells from their
surrounding matrix inevitably implies a certain amount of
damage to the ECM. Each of the tested decellularization
methods resulted in ECM damage. The SDS/RNase/DNase
method appeared to be the mildest treatment. It showed no
loss or disruption of the major structural components as
elastin and collagen. Only a loss of CS and FN in the valve
leaflet and a minor loss in the aortic wall was observed. The
media of the decellularized aortic wall was more compact
and thinner than an untreated aortic wall but is consistent
with earlier findings.13 In the rat aortic valve transplantation
model the morphology and ECM constitution of the decel-
lularized allograft conduits contrasted with the findings in
the cellular allograft conduits used as controls. Although the
number of animals per group was small, all the explanted
cellular allograft leaflets were deformed and swollen, with
severe damage to the elastin and collagen fibers accompa-
nied by a loss of CS. The morphology and ECM constitution
Figure 3. a to j, The valve leaflets of transplanted cellular allo-
geneic aortic conduits (left panel) were deformed and swollen
while the cells had disappeared (a, b). The collagen fibers were
less compact (Col; c) and there was a decrease of chondroitin
sulfate (CS; d). Transanastomotic intimal proliferations (I) were
positive for CS and fibronectin (FN; e). Transplanted acellular
allogeneic grafts (right panel) demonstrated normal valve leaflets
(f, g) with regular collagen (h) and glycosaminoglycans distribu-
tions (i, j). Arterial (A) and ventricular (V) side of the valve; valve
basis (B); valve leaflet (L); hematoxilin-eosin (HE).
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of the decellularized allograft conduits, however, appeared
almost normal. Furthermore, there was a complete loss of
valve cells in the cellular allogeneic group, which was not
observed in the cellular syngeneic group. This almost com-
plete loss of valve cells was accompanied by loss of ECM
structure, which is consistent with findings in allogeneic
transplantations in other rat aortic valve transplantation
studies.6,17
Transplanted cryopreserved homografts rapidly lose
their cellular components during the first year of implanta-
tion18 while the normal tissue architecture is damaged.19
Despite an increasing amount of evidence that aortic valve
allografts are capable of eliciting a cellular and humoral
immune response,4,20-22 it is not yet clear what exact role
the immune response plays in ECM damage of homografts.
A direct relationship between recipient immune activation
and structural valve failure is still not proven. An important
reason is the impossibility of having valvular biopsies in the
clinical setting. Immune suppression or human leukocyte
antigen matching for these reasons is applied almost no-
where in case of aortic valve allograft transplantations.
After transplantation indicators of immune-mediated injury
as persistent up-regulation of leukocyte adhesion mole-
cules23 and the presence of neutrophyl granulocytes and
depositions of antibodies and complement24 are missing.
We should bear in mind that these studies have missed the
immune response in an earlier phase after implantation.
Oei25,26 demonstrated in his MHC-mismatched rat valve
transplantation model an infiltration of recipient CD4,
CD8, and CD68 T cells and allogeneic antigen-present-
ing denditric cells (MHC class II) in the graft within 7 days
after transplantation. Influx of macrophages by local expres-
sion of cytokines and chemokines from the activated T cells
led to complete loss of stromal cells and distorted leaflet
structure at day 21. In the present study we demonstrated in
the same model that removal of the allogeneic MHC class I–
and II–expressing cells and cell debris in advance of the
transplantation prevents the immune-induced damage that
results from influx of lymphoid cells. Even in MHC-
matched valve allograft transplantations it can be argued
that decellularization of the valves will have a positive
effect on the survival and functionality of the valve in that
the dead cells caused by, for example, cryopreservation,
warm ischemia time, and/or mechanical damage also induce
a T-cell–mediated macrophage influx.
A complication in our model is that all decellularized
aortic valve conduits were not functional due to massive
sinus thrombus formation. This was also found in the cel-
lular allografts that became acellular. In the control cellular
synergrafts, however, thrombus formation was not ob-
served. Previous reports on decellularized valves are con-
tradictory. Decellularized aortic valves transplanted into the
pulmonary artery of the dog8 and porcine valves into the
right outflow tract of a sheep heart15 did not show thrombus
formation, although cryopreserved rat aortic valves with
almost no endothelial cells have a high incidence of throm-
bus formation in the sinuses.26 An explanation could be that
we used an heterotopic abdominal implantation in contrast
Figure 4. a to g, Several cases were seen with transanastomotic intimal proliferations (upper panel). In case of
intimal proliferation actin-positive intimal cells (I, a) expressing chondroitin sulfate (CS; b) and fibronectin (FN; c)
migrated into the acellular valve leaflet. Allogeneic acellular transplantation: arterial (A) and ventricular (V) side
of the valve; valve leaflet (L). The lower panel shows a normal untreated (d), decellularized (e), transplanted
allogeneic cellular (f) and a transplanted allogeneic acellular (g) aortic wall. Decellularization resulted in a
complete loss of cellular structures from both the media and adventitia (Adv), but the tunica media (M) became
more compact with smaller interlamellar spaces (e, g). Multifocal disruption of elastin laminae was often seen in
transplanted cellular allogeneic conduits (f). No loss or disruption of elastic fibers could be demonstrated in the
acellular allogeneic group, although the media had a more compact appearance.
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to orthotopic transplantations in other studies. Due to the
end-to-side implantation technique no physiological blood
flow profile could be obtained, which can result in thrombus
formation. The loss of endothelium, however, appeared to
be an essential condition in thrombus formation.
In both the acellular allograft and synergraft valve leaf-
lets ingrowth of transanastomotic intimal cells occurred. In
one acellular synergraft almost three quarters of the valve
leaflet was repopulated with SMC actin–positive cells.
These SMC actin–positive cells were capable of producing
the ECM molecules CS and FN. Interestingly, the loss of CS
and FN, which was observed after the decellularization
process, could be replenished by these cells. In the leaflets
that had little ingrowth of intimal proliferation cells no
replenishment of CS was seen. This unintended ingrowth of
myofibroblasts indicates that the scaffold is suitable for
repopulation and repair by autologous cells.
Although this study addressed the use of rat aortic valve
conduit allografts for tissue-engineering research, the avail-
ability of human allograft valves is still limited. Tissue
engineering of aortic valve xenografts could be a possible
solution in overcoming this problem, due to the unlimited
supply of porcine valves. The first tissue-engineered porcine
heart valve implantation trials in humans have already been
undertaken.15,27 However, decellularized arterial xenograft
transplantations from guinea pig to rat abdominal aorta
resulted in elastin degradation and aneurysmal dilatation,
most probably due to an interspecies immunogenicity of the
ECM.13 Although the first signs of these clinical trials are
promising, the future will show us whether transplanted
decellularized porcine valves have a better or worse prog-
nosis than the generally used glutaraldehyde-fixed porcine
valves. Meanwhile, further research is necessary to study
the possible effects of immune response to interspecies
ECM and to optimize decellularization techniques for hu-
man aortic valves.
Jan Lens is kindly acknowledged for his help in preparing the
figures. The technical assistance of Maria Borrias and Conny van
Munsteren is greatly appreciated.
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